Literature DB >> 20849864

Reelin as a putative vulnerability factor for depression: examining the depressogenic effects of repeated corticosterone in heterozygous reeler mice.

April L Lussier1, Raquel Romay-Tallón, Lisa E Kalynchuk, Hector J Caruncho.   

Abstract

We examined a potential two-hit murine animal model of depression by assessing whether a genetic deficit in reelin increases vulnerability to the depressogenic effects of the stress hormone corticosterone. Stress is an identified risk factor for the onset of depressive symptoms, but depression also has a significant genetic component, suggesting that environmental factors and genetic background likely interact in the etiology of depression. Previous results have revealed that reelin levels are decreased in post-mortem hippocampal tissue from patients with schizophrenia, bipolar disorder and depression, and also in an animal model of depression. Therefore, we hypothesized that heterozygous reeler mice (HRM), with approximately 50% normal levels of reelin, would be more sensitive to the depressogenic effects of corticosterone than wild-type mice (WTM). Mice received subcutaneous injections of either vehicle or 5 mg/kg, 10 mg/kg, or 20 mg/kg of corticosterone for 21 consecutive days, and then they were assessed for changes in depression-like behavior, hippocampal reelin expression, and hippocampal neurogenesis. Corticosterone produced dose-dependent increases in depression-like behavior and decreases in reelin expression, neurogenesis, and cell maturation regardless of mouse genotype. There were no differences between the vehicle-injected HRM and WTM in these measures. However, the effects of CORT on behavior, the number of reelin-positive cells in the subgranular zone or hilus, and hippocampal neurogenesis were more pronounced in the HRM than in the WTM, providing support for the idea that mice with impaired reelin signaling may be more vulnerable to the deleterious effects of glucocorticoids. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849864     DOI: 10.1016/j.neuropharm.2010.09.007

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  20 in total

1.  Fast-acting antidepressant-like effects of Reelin evaluated in the repeated-corticosterone chronic stress paradigm.

Authors:  Hector J Caruncho; Lisa E Kalynchuk; Kyle J Brymer; Jenessa Johnston; Justin J Botterill; Raquel Romay-Tallon; Milann A Mitchell; Josh Allen; Graziano Pinna
Journal:  Neuropsychopharmacology       Date:  2020-01-11       Impact factor: 7.853

2.  Corticosterone regulates the expression of neuropeptide Y and reelin in MLO-Y4 cells.

Authors:  Yuanyuan Ma; Xiangnan Wu; Xianxian Li; Jing Fu; Jiefei Shen; Xiaoyu Li; Hang Wang
Journal:  Mol Cells       Date:  2012-05-17       Impact factor: 5.034

3.  Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice.

Authors:  Andiara E Freitas; Javier Egea; Izaskun Buendia; Vanessa Gómez-Rangel; Esther Parada; Elisa Navarro; Ana Isabel Casas; Aneta Wojnicz; José Avendaño Ortiz; Antonio Cuadrado; Ana Ruiz-Nuño; Ana Lúcia S Rodrigues; Manuela G Lopez
Journal:  Mol Neurobiol       Date:  2015-05-13       Impact factor: 5.590

4.  Extracellular proteolysis of reelin by tissue plasminogen activator following synaptic potentiation.

Authors:  J H Trotter; A L Lussier; K E Psilos; H L Mahoney; A E Sponaugle; H-S Hoe; G W Rebeck; E J Weeber
Journal:  Neuroscience       Date:  2014-06-02       Impact factor: 3.590

5.  Neural stem cell grafting counteracts hippocampal injury-mediated impairments in mood, memory, and neurogenesis.

Authors:  Bharathi Hattiangady; Ashok K Shetty
Journal:  Stem Cells Transl Med       Date:  2012-09-05       Impact factor: 6.940

6.  Overexpression of Reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder.

Authors:  Cátia M Teixeira; Eduardo D Martín; Ignasi Sahún; Nuria Masachs; Lluís Pujadas; André Corvelo; Carles Bosch; Daniela Rossi; Albert Martinez; Rafael Maldonado; Mara Dierssen; Eduardo Soriano
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

7.  Prenatal stress down-regulates Reelin expression by methylation of its promoter and induces adult behavioral impairments in rats.

Authors:  Ismael Palacios-García; Ariel Lara-Vásquez; Juan F Montiel; Gabriela F Díaz-Véliz; Hugo Sepúlveda; Elías Utreras; Martín Montecino; Christian González-Billault; Francisco Aboitiz
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

8.  Reelin expression in brain endothelial cells: an electron microscopy study.

Authors:  Emma Perez-Costas; Erin Y Fenton; Hector J Caruncho
Journal:  BMC Neurosci       Date:  2015-03-24       Impact factor: 3.288

Review 9.  Epigenetic RELN Dysfunction in Schizophrenia and Related Neuropsychiatric Disorders.

Authors:  Alessandro Guidotti; Dennis R Grayson; Hector J Caruncho
Journal:  Front Cell Neurosci       Date:  2016-04-05       Impact factor: 5.505

Review 10.  Reelin Proteolysis Affects Signaling Related to Normal Synapse Function and Neurodegeneration.

Authors:  April L Lussier; Edwin J Weeber; G William Rebeck
Journal:  Front Cell Neurosci       Date:  2016-03-29       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.